MedTrace Logo

Pik Lenin High Altitude Research Expedition 2009

NCT01571687 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2012-04-05

No results posted yet for this study

Summary

Exposure to hypobaric hypoxia demands maximum effort of the body and can lead to high altitude illnesses. Recently, there is rising interest on coagulation activation during trekking and mountaineering in higher regions and on development of oxidative stress due to hypoxia. 30 volunteers have been examined during an high altitude research expedition to the 7134m high mount Pik Lenin in Kyrgyzstan to investigate mechanisms of coagulation activation and effects of antioxidant supplements on oxidative stress.

Conditions

  • Oxidative Stress
  • Cell-derived Microparticles

Interventions

DIETARY_SUPPLEMENT

antioxidant supplements

Intake of 6 tablets daily containing: 800 I.E. Vitamin E, 1000mg Vitamin C, 200000 I.E. Vitamin A, 600mg Acetylcystein.

DIETARY_SUPPLEMENT

Placebo

Intake of 6 identically appearing tablets daily containing placebo

Sponsors & Collaborators

  • Kantonsspital Aarau

    collaborator OTHER

  • Lotteriefonds des Kantons Aarau

    collaborator UNKNOWN

  • Schweizer Gesellschaft für Gebirgsmedizin

    collaborator UNKNOWN

  • University of Bern

    collaborator OTHER

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Andreas R Huber, Prof. Dr. med. · Center of Laboratory Medicine Cantonal Hospital Aarau and University of Bern

  • Jacqueline Pichler Hefti, Dr. med. · Division of Pneumology, Inselspital Bern, Universityhospital Bern

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01571687 on ClinicalTrials.gov